Table 2.

Initial findings of clinical abnormalities, abnormal karyotype, and ras point mutations

VariableNo. of patients (%*)
AHD 151  (70.9) 
Splenomegaly 61  (30.7)  
Hepatomegaly 38  (18.9) 
Enlarged lymph nodes 28  (13.9)  
Previous malignancy 34  (16)  
Abnormal karyotype 70  (34.1)  
ras point mutation 25  (38.4) 
VariableNo. of patients (%*)
AHD 151  (70.9) 
Splenomegaly 61  (30.7)  
Hepatomegaly 38  (18.9) 
Enlarged lymph nodes 28  (13.9)  
Previous malignancy 34  (16)  
Abnormal karyotype 70  (34.1)  
ras point mutation 25  (38.4) 
*

Percentages calculated on the basis of data availability.

Data available for 65 patients.

Close Modal

or Create an Account

Close Modal
Close Modal